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It is now clearly established, on the basis of results from
family, twin, and adoption studies, that genetic factors
play a major role in the etiology of schizophrenia
(McGuffin et al. 1994). Studies of the risks of recurrence
in various classes of relatives have allowed us to exclude
the possibility that schizophrenia is either a single-gene
disorder or a collection of single-gene disorders, even
when incomplete penetrance is taken into account.
Rather, in schizophrenia, the mode of transmission, like
that of other common disorders, is complex and non-
Mendelian (McGue and Gottesman 1989). The most
common mode of transmission probably involves mul-
tiple susceptibility loci (McGuffin et al. 1995), but the
number of such loci, the risk for disease conferred by
each locus, and the degree of interaction between loci
all remain unknown. The contribution of individual
genes to the familiality of a disorder can be expressed
in terms of the locus-specific ls, which measures, among
siblings of affected individuals, the risk resulting from
possession of the disease allele, relative to the popula-
tion-specific background risk. Risch (1990) has calcu-
lated that, whereas, among siblings, the overall relative
risk for schizophrenia is ∼10, the data are incompatible
with the existence of a single locus of ls 1 3 and, unless
extreme epistasis exists, models with two or three loci
of ls  2 are more plausible. To put this in perspective,
in diabetes, the ls for the major-histocompatibility-com-
plex locus is estimated to be ∼3.
It is, however, difficult to exclude the possibility that
genes of major effect are operating in a small proportion
of cases, and it was with the hope of confirming this
possibility that the first wave of molecular genetic studies
of schizophrenia focused on parametric linkage analysis
in large multiply affected pedigrees.More recently,many
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groups have applied allele-sharing methods of linkage
to schizophrenia, in the belief that such methods are
more appropriate for complex diseases. To date, the
strongest conclusions that can be drawn from both kinds
of analysis are that single-gene forms of schizophrenia
are, at most, extremely rare and are probably nonexist-
ent and that the predictions made by Risch (1990) are
most likely correct. It is unlikely that a locus with an
effect size of ls 1 3 exists, but there is suggestive evidence
implicating that a number of regions are consistent for
the existence of at least some genes of moderate effect
(ls 1.5–3). Unfortunately, none of these “linkages” can
be regarded as unequivocal, nor are they sufficiently pre-
cise to launch large-scale efforts aimed at cloning disease
genes. Thus, although the use of linkage methods has
resulted in some progress in the pursuit of genes, this
progress has largely consisted of delineations of what is
not the case rather than determinations of the unequiv-
ocal location of susceptibility genes.
Seeking Genes for Schizophrenia through Association
Given the difficulties inherent in detecting, by means
of linkage, genes of small to modest effect, it is not sur-
prising that many researchers have sought to take ad-
vantage of the potential of candidate-gene association
studies to identify such genes (Risch and Merikangas
1996), and it is these studies that we shall consider in
this review. Although they provide a potentially pow-
erful means of identifying genes of small effect, associ-
ation studies are not without their problems. For such
enigmatic disorders as schizophrenia, the choice of can-
didate genes is limited only by the imagination and re-
sources of the researcher. This places a very stringent
burden of statistical proof on positive results, because
of low prior probability and issues of multiple testing
(Owen et al. 1997). Furthermore, case-control associa-
tion studies can generate false positives as a result of
population stratification. This problem can be addressed
by the use of family-based association methods (Schaid
and Sommer 1994), but because of stigma, adult age at
onset, and the disruptive effects of mental illness on fam-
ily relationships, family-based samples may be limited
in size. Consequently, family-based studies may intro-
duce results that are more spurious than those of case-
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control studies (Risch and Teng 1998). It would seem
unwise, therefore, to discard the case-control study de-
sign, which has served epidemiology so well throughout
the years.
Association samples are also prone to type 2 errors,
simply because they are often underpowered; therefore,
to draw satisfactory conclusions from studies with neg-
ative results, sample sizes that are larger than those typ-
ically used, to date, in psychiatric genetics are required
(Owen et al. 1997). Further problems arise when dif-
ferent association studies reach contradictory conclu-
sions. In different ethnic groups, differences in the ap-
parent contribution of a given allele can always be
ascribed to different allele frequencies either at the locus
of interest or at the interacting loci; however, this con-
venient explanation is typically difficult to test. Further
potential for heterogeneity occurs if the association with
the marker is a result of tight linkage with the true sus-
ceptibility allele or if different subtypes of the disease
exist. Under these circumstances, no two studies can be
considered identical for the purpose of testing a candi-
date-gene hypothesis; this makes it difficult to draw de-
finitive conclusions from conflicting findings. However,
it is worth remembering that the purpose of experimen-
tation is to reject a null hypothesis and that, in the face
of uncertainty, the burden of proof remains with the
proponents of a particular candidate gene.
Most candidate-gene studies have derived their func-
tional authority from neuropharmacological studies sug-
gesting that abnormalities in monoamine neurotrans-
mission—in particular, dopaminergic and serotonergic
systems—play a role in the etiology of schizophrenia.
Overall, the results presented in this extensive literature
are disappointing; however, it should be noted that the
sample sizes in many of the older studies would now
generally be regarded as inadequate, particularly since
the polymorphic markers in question did not, in them-
selves, represent functional variants and since few genes
have been systematically screened, even for common var-
iants. Recently, however, there have been more-prom-
ising reports of candidate-gene associations, three of
which are considered below.
Serotonin 5HT2a Receptor Gene
Many of the newer drugs that are used to treat schizo-
phrenia were selected because of their effects on the ser-
otonergic transmitter system, and they specifically target
the 5HT2a receptor. The first genetic evidence that this
receptor might play a role in schizophrenia came from
a Japanese study group that reported an association be-
tween a TrC polymorphism at nucleotide 102 in the
5HT2a receptor gene (Inayama et al. 1996). This finding
was pursued by a large European consortium consisting
of seven centers and involving 571 patients and 639
controls. The consortium’s findings replicated those of
the Japanese study (Williams et al. 1996), results that
our group subsequently replicated by use of a family-
based design (Spurlock et al. 1998). Many other studies
have followed and, as expected, have produced divergent
results. Fortunately, the task of interpreting these con-
flicting data has been simplified by a recentmeta-analysis
of all available data on 13,000 subjects. The results of
this analysis support the original finding (P = .0009),
and a funnel-plot of these data—in which the number
of subjects in each study is plotted against the odds ratio
(OR) obtained—suggests an absence of publication bias
(Williams et al. 1997).
Since this analysis was undertaken, a few reports with
negative findings have appeared; however, none have
approached the sample sizes required, because the pu-
tative OR for the C allele is only 1.2 (Williams et al.
1997). To obtain power 1.80 to detect an effect of this
size, even at a criterion of a = .05, a sample size of 1,000
subjects is required. Is, then, this association real? The
sample sizes used, to date, make the negative results of
studies effectively meaningless, but it is also true that a
significance level of P = .0009 is not definitive. At pre-
sent, all we can conclude is that the balance of evidence
favors an association between the T102C 5HT2a poly-
morphism and schizophrenia; nevertheless, the burden
of proof has not yet been met.
If the association is real, it is far from clear that T102C
is the susceptibility variant per se, since this nucleotide
change neither alters the predicted amino acid sequence
of the receptor protein nor occurs in a region of obvious
significance for regulation of expression. We have there-
fore extended the analysis of this gene and have iden-
tified, in the promoter, one polymorphism that is also
associated with schizophrenia but that is of no known
functional consequence (Spurlock et al. 1998). Recent
evidence may indicate that other possibly functional se-
quence variants have yet to be identified (Bunzel et al.
1998).
Dopamine D3 Receptor Gene
For more than three decades, the hypothesis that
schizophrenia is caused by excessive dopaminergic neu-
rotransmission has dominated biological thinking about
this disorder. Conventional wisdom, which has as its
basis the presumed mode of action of therapeutic drugs,
has favored disordered transmission at the D2 receptor;
however, with few exceptions, the results of candidate-
gene studies of an association between D2 and schizo-
phrenia have been negative. Nevertheless, after com-
pleting a series of studies in which the effects of drugs
on neuroreceptor-gene expression were examined, we
and our colleagues reported evidence of an association
between schizophrenia and homozygosity for a Ser9Gly
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polymorphism in exon 1 of the dopamine-receptor gene
DRD3 (Crocq et al. 1992). This receptor is functionally
similar to DRD2 and is expressed in regions of the CNS
believed to be involved in the pathogenesis of schizo-
phrenia. As with the results of studies of an association
between 5HT2a and schizophrenia, these results were
subsequently confirmed in independent samples, includ-
ing one family-based study (Williams et al. 1998); how-
ever, several studies with negative results were also re-
ported. Fortunately, as before, our analysis is facilitated
by a meta-analysis of data from 15,000 individuals; our
results revealed a small OR of 1.23 but a significant (P
= .0002) association—one that could not easily be as-
cribed to selective publication—between homozygosity
for the Ser9Gly polymorphism and schizophrenia (Wil-
liams et al. 1998). With reference to the negative study
results that will inevitably appear in the future, we es-
timate that to obtain power 1.80 to detect an effect of
this size, with a significance level of P = .05, a sample
of 1,500 cases and 1,500 controls will be required, if
we assume, as appears to be the case, that the frequency
of homozygosity in controls is .5.
At present, then, the status of the DRD3 finding is
similar to that of the 5HT2a finding; in other words, at
present, the balance of evidence favors association, but
the null hypothesis still cannot be confidently rejected.
So far, no other polymorphisms that might explain the
putative DRD3 associations have been found, but our
group has recently identified several polymorphisms in
previously unknown exons located 5′ to the exon pre-
viously referred to as exon 1 (P. Buckland, M. C.
O’Donovan, and M. J. Owen, unpublished data). We
are currently testing these polymorphisms in our patient
samples to establish whether, in this region, variants in
linkage disequilibrium with the Ser9Gly polymorphism
might provide a more functionally plausible explanation
of our findings.
Anticipation, Trinucleotide Repeats, and KCa3
The first description of anticipation was made in con-
nection with severe mental disorder (Morel 1857), but
this observation generated little more than controversy
until it was discovered that dynamic mutations are at
least one of the molecular mechanisms responsible. As
discussed by O’Donovan and Owen (1996b), the results
of a series of studies that applied modern diagnostic
criteria appear to confirm that the inheritance of schizo-
phrenia is consistent with anticipation, which raises the
possibility that an unstable trinucleotide repeat accounts
for the complex pattern of inheritance in this disorder
(Petronis and Kennedy 1995). Indeed, two study groups,
both of which applied the repeat-expansion–detection
(RED) method, almost simultaneously reported that the
maximum length of the most common known patho-
genic trinucleotide repeat, CAG/CTG, was greater in pa-
tients with schizophrenia than in unaffected controls
(Morris et al. 1995; O’Donovan et al. 1995); these find-
ings were later replicated in a European multicenter
study (O’Donovan et al. 1996a). However, these RED
studies were followed by a series of unsuccessful at-
tempts to identify the relevant repeat-containing loci by
means of (1) screening individual CAG/CTG-repeat loci,
(2) cloning and screening CAG/CTG-repeat–containing
candidate genes, or (3) examining, by use of an antibody
that recognizes long polyglutamine arrays, protein ex-
tracts from tissues originating in schizophrenic pro-
bands. The negative results of these attempts, combined
with some failures to replicate the RED findings (Laurent
et al. 1998; Li et al. 1998a; Vincent et al. 1999), tem-
pered the enthusiasm that arose as a result of reports of
the earlier data. Nevertheless, the trinucleotide-repeat
hypothesis was reinvigorated with the report of there
being an association between schizophrenia and the al-
leles of KCa3, a member of the family of calcium-acti-
vated potassium channels (hKCa3/KCCN3; Chandy et
al. 1998).
For several reasons, KCa3 seemed to be a remarkable
candidate gene for schizophrenia. First, the gene con-
tained two CAG repeats, both of which encoded poly-
glutamine arrays in the amino terminal of the protein,
with one repeat being highly polymorphic. Second, the
family of genes to which KCa3 belongs is thought to
play an important role in the regulation of neuronal
activity. Third, the KCa3 gene was reported to map to
chromosome 22q11, near a region that had previously
been implicated, by means of linkage, as containing a
susceptibility gene for schizophrenia. On the basis of
these arguments, to assess the involvement of KCa3 in
schizophrenia, Chandy and colleagues (1998) conducted
a case-control study in which subjects of French/Alsatian
ancestry were evaluated with a supplemental sample of
North American white subjects. The distributions of re-
peat size were significantly different between cases and
controls, both in the European samples alone and in the
combined sample. When alleles were dichotomized, at
the modal repeat size, into large (20 repeats) or small
(19 repeats) alleles, the large alleles were more com-
monly found in the patient group (Fisher’s exact test, P
= .0035). To date, there are insufficient data sets avail-
able for an extensive meta-analysis; however, the results
of two further case-control studies have subsequently
lent support to the findings of Chandy and colleagues
(1998). First, Bowen et al. (1998) have applied the same
method of dichotomization used by Chandy and col-
leagues (1998) and have found very modest evidence for
there being larger alleles in schizophrenics (P = .047, one
tail). Second, Dror et al. (1999), in their sample of 84
Israeli Ashkenazi patients with schizophrenia and 102
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unaffected Ashkenazi controls (P = .00017), provided
much stronger evidence for an association.
Although evidence from three case-control studies
lends support to the hypothesis that KCa3 is a suscep-
tibility gene for schizophrenia, in other respects, the case
for KCa3 being a candidate gene has been considerably
weakened. First, several study groups that became aware
that the positional evidence was flawed showed that
KCa3 maps not to 22q11 but, rather, to 1q21 (Austin
et al. 1999; Dror et al. 1999). Second, the RED data
cited above lend no support to KCa3 being a candidate
gene, since, in this gene, the polymorphic trinucleotide
repeat, which extends to a maximum tract length of 30
repeats, is too short to account for the RED associations
(Bowen et al. 1998). Third, in a series of family-based
studies (Li et al. 1998b; Sto¨ber et al. 1998; Wittekindt
et al. 1999), there is no evidence for intergenerational
instability of KCa3, and in two of the studies (Bowen
et al. 1998; Dror et al. 1999), large repeats were mod-
estly but significantly associated with later age at onset
of symptoms. Thus, the evidence for anticipation pro-
vides no support for KCa3 having a role in
schizophrenia.
Regardless of the a priori evidence, the case for an
association between KCa3 and schizophrenia will ulti-
mately rest on a body of convincing replications. The
results of four family-based association studies have now
been reported. In the largest of these studies (Wittekindt
et al. 1999), a mixture of probands from multiplex fam-
ilies (49 families, 110 affected-parent trios) and simplex
families (83 affected-parent trios) was examined. All
subjects were of German origin, which is the same ethnic
origin of the subjects studied by Chandy et al. (1998).
However, in contrast to the results of the earlier report,
the findings of Wittekindt et al. (1999) show a trend
toward excess transmission of the smaller allele. The
results of both a smaller German study (Sto¨ber et al.
1998) and a Chinese family-based study (Li et al. 1998b)
have confirmed this deficit of transmission of the larger
alleles to affected family members. Sto¨ber et al. (1998)
attained conventional levels of significance (P = .014, by
simulation), whereas, in the Chinese sample, deficit of
transmission of the large CAG20 allele was nonsignifi-
cant after the required correction for multiple testing.
Finally, a fourth American family-based study also failed
to support the finding of excess transmission of large
alleles to affected probands (Austin et al. 1999).
Taken together, the results of these family-based as-
sociation studies and three additional case-control stud-
ies (Bonnet-Brilhault et al. 1999; Joober et al. 1999; Tsai
et al. 1999) do not support the hypothesis that large
alleles of the KCa3 gene contribute to susceptibility to
schizophrenia. Thus, we are left in a familiar position
in candidate-gene analysis of complex diseases. Assum-
ing an OR of ∼2, such as that in the study by Chandy
et al. (1998), we have calculated that, both in our own
sample (Bowen et al. 1998) and in the large German
sample (Wittekindt et al. 1999), there was power 195%
in the detection of an association at P = .05. However,
if, as we observed, the true OR is ∼1.3, then the studies
with negative results are underpowered (Bowen et al.
1998). In view of the (marginal) evidence, from some of
the family-based studies, for an association between
schizophrenia and small alleles, linkage disequilibrium
between a susceptibility allele and different CAG-repeat
haplotypes in different populations has been proposed
as an explanation. However, this is unlikely in view of
the ethnic similarities of the Alsatian (Chandy et al.
1998) and German (Wittekindt et al. 1999) subjects.
Although, at present, there are insufficient peer-reviewed
data from which to draw firm conclusions, we believe
the case for an association between KCa3 and schizo-
phrenia remains with the null hypothesis.
What, then, should we make of the original associa-
tions between large CAG/CTG repeats and schizophre-
nia? It has been reported that large CAG/CTG RED
products (repeat size 140) are explained by the repeat
size at two autosomal loci, one at 18q21.1 and the other
at 17q21.3 (Lindblad et al. 1998; Sidransky et al. 1998).
If this is correct, one or both of these loci could be
associated with schizophrenia. Unfortunately, data pre-
sented by Vincent and colleagues (1999) and data from
our group (O’Donovan and Owen, unpublished data)
unequivocally show that expansions at these loci are not
responsible for the RED associationswith schizophrenia.
However, in both samples, after establishing a cutoff
with a repeat size 140, only ∼50% of large CAG/CTG
repeats that were detected by RED could be explained
by polymorphisms at these two loci. This indicates that
at least one additional locus is responsible for our RED
data, a possibility that is supported by two recent studies
of protein extracts from schizophrenic tissues (Ross
1999). Because other studies show that virtually all large
RED CAG/CTG products are explained by the loci at
17q and 18q, our results must indicate either ethnic het-
erogeneity or methodological differences in the earlier
studies in which RED was used.
Concluding Remarks
To date, neither linkage nor association approaches
have unequivocally identified genes for schizophrenia,
although there are suggestive data implicating alleles of
5HT2a and DRD3 genes. If these data can only be re-
garded as suggestive, then the data on the KCa3 gene
and large anonymous CAG/CTG repeats now generally
favor the null hypothesis.
Some might question the importance of candidate-
gene studies that reflect, at best, the operation of genes
of very small effect. We contend there are two important
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justifications for pursuing such genes. First, if 5HT2a
and DRD3 polymorphisms are associated with schizo-
phrenia, it indicates that hypotheses concerning the eti-
ology of this disorder are at least partially correct. Such
a finding would lay to rest concerns that the neurophys-
iological features that are considered to be potential
causes of psychiatric disorders really represent conse-
quences of the disease state. Second, even small risk fac-
tors can, if they are common, significantly contribute to
population-wide risk. For example, the attributable frac-
tion associated with the possession of allele C of the
T102C polymorphism in 5HT2A is likely to be relatively
high (.35), since this allele is common in the general
population (Williams et al. 1996). In the coming years,
given the difficulties of positional cloning and doubts
about the feasibility of linkage disequilibrium mapping
in complex disorders, it is likely that more attention will
focus on candidate genes. Therefore, it will be critical
that researchers have access to (1) adequate sample sizes,
from both case-control and family-based studies, to de-
rive meaningful statistical evidence and (2) the new tech-
nologies that allow hundreds of candidate-gene hypoth-
eses to be tested, that permit genes to be more rigorously
screened for polymorphisms, and that permit mass
genotyping.
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